Tag: Tom Jantsch
Kansas City’s life sciences ecosystem continues to expand, the founders of Ronawk said Monday, celebrating plans for the Overland Park biotech company’s chief scientific officer to launch her own venture — returning to her roots in diagnostics and drug development, and growing the region’s culture of innovation. Dr. Amy Manning-Boğ is transitioning from her role…
Read More >
A Kansas biotech startup’s new manufacturing partner will boost efforts to automate and mass produce Ronawk’s headline-grabbing Bio-Block technology — a platform that has already accelerated medical advancements in tissue therapy. “Collaboration is critical for turning research advances into commercial therapies rapidly. The complexity and diversity of modalities is so big that nobody can do…
Read More >
Ronawk’s Bio-Block Universe has already revolutionized cell and tissue production, Tom Jantsch said, and the recent investment of $6.5 million is set to further research and development. “We have really changed the paradigm of how not only cell culture is done, but how researchers are able to scale. They can go from the bench, all…
Read More >
Synergy and chemistry are just as important as expertise when hiring strategic, high-level positions within a startup, said A.J. Mellott. “Ronawk has gone from this startup with its organized chaos, to having structured pathways that have emerged because we are better informed. That in itself has been really exciting and stimulating. We are more of…
Read More >